ALNYLAM PHARMACEUTICALS, INC. | Collaboration Agreements | Business Contracts

License and Collaboration Agreement dated as of February 3, 2013 by and among The Medicines Company and the Registrant (Filed With SEC on February 23, 2023)

Amendment No. 2 to License and Collaboration Agreement, dated as of October 31, 2022 between the Registrant and The Medicines Company (Filed With SEC on February 23, 2023)

Amendment to License and Collaboration Agreement, dated as of November 22, 2019 between the Registrant and The Medicines Company (Filed With SEC on February 13, 2020)

Amendment No. 3 entered into as of April 8, 2019 to the Master Collaboration Agreement dated as of January 11, 2014, as amended by Amendment No. 1 and Amendment No. 2, including... (Filed With SEC on August 6, 2019)

ALNYLAM PHARMACEUTICALS, INC. (40) | Collaboration Agreements (4)